Lab Benefit Management Program - Clinical Payment and Coding Policies
Refer to the Clinical Payment and Coding Policies page for general information and disclaimers about these policies.
Policy Name | CPCP Number | Posted | Effective Date | Archived Documents |
---|---|---|---|---|
Allergen Testing | CPCPLAB013 | 02/01/2022 | 05/01/2022 | N/A |
ANA/ENA Testing | CPCPLAB011 | 02/01/2022 | 05/01/2022 | N/A |
β-Hemolytic Streptococcus Testing | CPCPLAB053 | 02/01/2022 | 05/01/2022 | N/A |
Cardiac Biomarkers for Myocardial Infarction | CPCPLAB046 | 02/01/2022 | 05/01/2022 | N/A |
Cardiovascular Disease Risk Assessment | CPCPLAB020 | 02/01/2022 | 05/01/2022 | N/A |
Celiac Disease Testing | CPCPLAB017 | 02/01/2022 | 05/01/2022 | N/A |
Cervical Cancer Screening | CPCPLAB002 | 02/01/2022 | 05/01/2022 | N/A |
Coronavirus Testing in the Outpatient Setting | CPCPLAB057 | 02/01/2022 | 05/01/2022 | N/A |
Diagnosis of Idiopathic Environmental Intolerance | CPCPLAB023 | 02/01/2022 | 05/01/2022 | N/A |
Diagnosis of Vaginitis including Multi-target PCR Testing | CPCPLAB059 | 02/01/2022 | 05/01/2022 | N/A |
Diagnostic Testing of Common Sexually Transmitted Infections | CPCPLAB051 | 02/01/2022 | 05/01/2022 | N/A |
Diagnostic Testing of Influenza | CPCPLAB033 | 02/01/2022 | 05/01/2022 | N/A |
Diagnostic Testing of Iron Homeostasis & Metabolism | CPCPLAB008 | 02/01/2022 | 05/01/2022 | N/A |
DNA Ploidy Cell Cycle Analysis | CPCPLAB066 | 02/01/2022 | 05/01/2022 | N/A |
Epithelial Cell Cytology in Breast Cancer Risk Assessment | CPCPLAB024 | 02/01/2022 | 05/01/2022 | N/A |
Erectile Dysfunction | CPCPLAB041 | 02/01/2022 | 05/01/2022 | N/A |
Evaluation of Dry Eyes | CPCPLAB043 | 02/01/2022 | 05/01/2022 | N/A |
Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing | CPCPLAB025 | 02/01/2022 | 05/01/2022 | N/A |
Fecal Calprotectin Testing in Adults | CPCPLAB026 | 02/01/2022 | 05/01/2022 | N/A |
Flow Cytometry | CPCPLAB001 | 02/01/2022 | 05/01/2022 | N/A |
Folate Testing | CPCPLAB048 | 02/01/2022 | 05/01/2022 | N/A |
Gamma-glutamyl Transferase | CPCPLAB056 | 02/01/2022 | 05/01/2022 | N/A |
General Inflammation Testing | CPCPLAB049 | 02/01/2022 | 05/01/2022 | N/A |
Genetic Testing for Adolescent Idiopathic Scoliosis | CPCPLAB060 | 02/01/2022 | 05/01/2022 | N/A |
Helicobacter Pylori Testing | CPCPLAB018 | 02/01/2022 | 05/01/2022 | N/A |
Hemoglobin A1c | CPCPLAB004 | 02/01/2022 | 05/01/2022 | N/A |
Hepatitis C | CPCPLAB015 | 02/01/2022 | 05/01/2022 | N/A |
Identification of Microorganisms Using Nucleic Acid Probes | CPCPLAB063 | 02/01/2022 | 05/01/2022 | N/A |
Immune Cell Function Assay | CPCPLAB028 | 02/01/2022 | 05/01/2022 | N/A |
Immunohistochemistry | CPCPLAB069 | 02/01/2022 | 05/01/2022 | N/A |
In Vitro Chemoresistance and Chemosensitivities Assays | CPCPLAB030 | 02/01/2022 | 05/01/2022 | N/A |
Intracellular Micronutrient Analysis | CPCPLAB029 | 02/01/2022 | 05/01/2022 | N/A |
Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease | CPCPLAB035 | 02/01/2022 | 05/01/2022 | N/A |
Lyme Disease | CPCPLAB044 | 02/01/2022 | 05/01/2022 | N/A |
Measurement of Thromboxane Metabolites for ASA Resistance | CPCPLAB031 | 02/01/2022 | 05/01/2022 | N/A |
Nerve Fiber Density Testing | CPCPLAB064 | 02/01/2022 | 05/01/2022 | N/A |
Onychomycosis Testing | CPCPLAB068 | 02/01/2022 | 05/01/2022 | N/A |
Oral Screening Lesion Identification Systems and Genetic Screening | CPCPLAB032 | 02/01/2022 | 05/01/2022 | N/A |
Pancreatic Enzyme Testing for Acute Pancreatitis | CPCPLAB047 | 02/01/2022 | 05/01/2022 | N/A |
Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing | CPCPLAB055 | 02/01/2022 | 05/01/2022 | N/A |
Pathogen Panel Testing | CPCPLAB045 | 02/01/2022 | 05/01/2022 | N/A |
Pediatric Preventive Screening | CPCPLAB016 | 02/01/2022 | 05/01/2022 | N/A |
Plasma HIV-1 and HIV-2 RNA Quantification for HIV Infection | CPCPLAB065 | 02/01/2022 | 05/01/2022 | N/A |
Prenatal Screening | CPCPLAB014 | 02/01/2022 | 05/01/2022 | N/A |
Prenatal Screening for Fetal Aneuploidy | CPCPLAB022 | 02/01/2022 | 05/01/2022 | N/A |
Pre-Operative Testing | CPCPLAB012 | 02/01/2022 | 05/01/2022 | N/A |
Prescription Medication and Illicit Drug Testing in the Outpatient Setting | CPCPLAB070 | 02/01/2022 | 05/01/2022 | N/A |
Preventive Screening in Adults | CPCPLAB007 | 02/01/2022 | 05/01/2022 | N/A |
Prostate Biopsies | CPCPLAB005 | 02/01/2022 | 05/01/2022 | N/A |
Prostate Specific Antigen Testing | CPCPLAB006 | 02/01/2022 | 05/01/2022 | N/A |
Salivary Hormone Testing | CPCPLAB034 | 02/01/2022 | 05/01/2022 | N/A |
Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases | CPCPLAB036 | 02/01/2022 | 05/01/2022 | N/A |
Serum Tumor Markers for Malignancies | CPCPLAB037 | 02/01/2022 | 05/01/2022 | N/A |
ST2 Assay for Chronic Heart Failure | CPCPLAB040 | 02/01/2022 | 05/01/2022 | N/A |
Testing for Alpha-1 Antitrypsin Deficiency | CPCPLAB061 | 02/01/2022 | 05/01/2022 | N/A |
Testing for Diagnosis of Active or Latent Tuberculosis | CPCPLAB027 | 02/01/2022 | 05/01/2022 | N/A |
Testing for Mosquito or Tick-Related Infections | CPCPLAB052 | 02/01/2022 | 05/01/2022 | N/A |
Testing of Homocysteine Metabolism-Related Conditions | CPCPLAB067 | 02/01/2022 | 05/01/2022 | N/A |
Testosterone Testing | CPCPLAB009 | 02/01/2022 | 05/01/2022 | N/A |
Thyroid Disease Testing | CPCPLAB019 | 02/01/2022 | 05/01/2022 | N/A |
Urinary Tumor Markers for Bladder Cancer | CPCPLAB038 | 02/01/2022 | 05/01/2022 | N/A |
Urine Culture Testing for Bacteria | CPCPLAB050 | 02/01/2022 | 05/01/2022 | N/A |
Vectra DA Blood Test for Rheumatoid Arthritis | CPCPLAB039 | 02/01/2022 | 05/01/2022 | N/A |
Venous and Arterial Thrombosis Risk Testing | CPCPLAB058 | 02/01/2022 | 05/01/2022 | N/A |
Vitamin B12 and Methylmalonic Acid Testing | CPCPLAB010 | 02/01/2022 | 05/01/2022 | N/A |
Vitamin D | CPCPLAB003 | 02/01/2022 | 05/01/2022 | N/A |
ZIKA Virus Risk Assessment | CPCPLAB042 | 02/01/2022 | 05/01/2022 | N/A |